# Mylan Laboratories Limited (FDF-2) – FDA Inspection, May 16, 2014

Source: https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/53ebc2c6-eeb9-4b2d-8a99-ac4237992fe3
Source feed: FDA_Inspections

> FDA inspection 884211 of Mylan Laboratories Limited (FDF-2), May 16, 2014. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 884211
- Company Name: Mylan Laboratories Limited (FDF-2)
- Inspection Date: 2014-05-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1253435 - 2023-02-03](https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/c86b2c6d-3939-43ca-9c49-3ab1f5c1b33f)
- FDA Inspection 1122884 - 2020-02-28
- FDA Inspection 1091217 - 2019-04-26
- [FDA Inspection 1012796 - 2017-05-26](https://www.keypedia.com/records/fda_inspections/mylan-laboratories-limited-fdf-2/c3b3d8ef-b5cf-4868-ab95-1933bf124403)
- FDA Inspection 775616 - 2012-03-09

Company: https://www.keypedia.com/companies/mylan-laboratories-limited-fdf-2/1bcb64f5-f3f2-412e-81da-b3efab26f310

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c